Inactive Instrument
Epigenomics AG Stock Xetra
Stocks
DE000A1K0516
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Xetra
|
||
| - EUR | - |
|
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-07-22 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 1.01M 1.16M 947K 862K 1.62M 111M 1.65M 11.12M 4.34M 55.65M 4.37M 4.27M 185M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.98M 13.81M 11.24M 10.24M 19.24M 1.32B 19.55M 132M 51.59M 661M 51.84M 50.71M 2.2B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 2023-02-28 |
Alexander Link
BRD | Director/Board Member | 55 | 2020-05-31 |
Jochen Hummel
BRD | Director/Board Member | 56 | 2024-02-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.13% | -0.57% | +93.21% | +288.25% | 4.03B | |
| -4.66% | -7.69% | +48.07% | +69.38% | 3.59B | |
| -3.26% | +50.23% | +192.38% | -7.65% | 3.05B | |
| +0.15% | +4.13% | +280.26% | +432.36% | 2.45B | |
| +3.97% | +6.34% | -19.72% | -28.79% | 2.3B | |
| -3.75% | +5.87% | +9.27% | - | 1.3B | |
| -0.16% | +13.73% | +17.28% | +44.02% | 1.03B | |
| 0.00% | -9.83% | +114.87% | -44.10% | 861M | |
| +0.75% | +10.50% | -36.33% | -0.10% | 563M | |
| Average | -1.12% | +8.52% | +77.70% | +94.17% | 2.13B | |
| Weighted average by Cap. | -1.80% | +10.57% | +98.29% | +133.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.68K 22.53K 20.52K 38.55K 2.64M 39.19K 265K 103K 1.32M 104K 102K 4.41M |
| Net income | -3.35M -3.87M -3.15M -2.87M -5.38M -369M -5.47M -36.96M -14.44M -185M -14.51M -14.19M -616M | -314K -362K -295K -268K -504K -34.55M -513K -3.46M -1.35M -17.33M -1.36M -1.33M -57.75M |
| Net Debt | 10.46M 12.06M 9.82M 8.94M 16.8M 1.15B 17.07M 115M 45.04M 577M 45.26M 44.27M 1.92B | 10.97M 12.65M 10.3M 9.38M 17.62M 1.21B 17.91M 121M 47.24M 605M 47.47M 46.44M 2.02B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
